FDA.report

Application 040792

Type
ANDA
Sponsor
AUROBINDO PHARMA

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001CARISOPRODOLCARISOPRODOLTABLET;ORAL350MGNoNo
002CARISOPRODOLCARISOPRODOLTABLET;ORAL250MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
16571-780carisoprodolcarisoprodolRising Pharma Holdings, Inc.ANDACurrent
16571-780carisoprodolcarisoprodolRising Pharma Holdings, Inc.ANDACurrent
16571-781carisoprodolcarisoprodolRising Pharma Holdings, Inc.ANDACurrent
16571-781carisoprodolcarisoprodolRising Pharma Holdings, Inc.ANDACurrent
64980-380carisoprodolcarisoprodolRising Pharmaceuticals, Inc.ANDACurrent
64980-380carisoprodolcarisoprodolRising Pharmaceuticals, Inc.ANDACurrent
64980-380carisoprodolcarisoprodolRising Pharmaceuticals, Inc.ANDACurrent
64980-381carisoprodolcarisoprodolRising Pharmaceuticals, Inc.ANDACurrent
64980-381carisoprodolcarisoprodolRising Pharmaceuticals, Inc.ANDACurrent
64980-381carisoprodolcarisoprodolRising Pharmaceuticals, Inc.ANDACurrent
65862-158carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-158carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-158carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-158carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-158carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-693carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-693carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-693carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-693carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
65862-693carisoprodolcarisoprodolAurobindo Pharma LimitedANDACurrent
71335-9613carisoprodolcarisoprodolBryant Ranch PrepackANDACurrent
72189-386CarisoprodolCarisoprodolDirect_RxANDACurrent
72189-386CarisoprodolCarisoprodolDirect_RxANDACurrent